Verus Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Verus Wealth Management's LLY Position: Q1 2026 in Review
Verus Wealth Management increased its Eli Lilly (LLY) stake by 0.29% in Q1 2026, buying an estimated $1.01K and bringing the position to 344 shares worth $316K. The position accounts for 0.29% of the portfolio, ranked #43.
Verus Wealth Management first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $369K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Verus Wealth Management held 344 shares of Eli Lilly worth $316K as of Q1 2026.
- Verus Wealth Management bought 1 Eli Lilly share in Q1 2026, an estimated $1.01K.
- Eli Lilly made up 0.29% of Verus Wealth Management's portfolio in Q1 2026, its #43 holding.
- Verus Wealth Management first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
- Verus Wealth Management's Eli Lilly position peaked at $369K in Q4 2025.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Verus Wealth Management's 13F filing for Q1 2026, filed 24 Apr 2026.